Resultados de la búsqueda

Farkouh ME, Stone GW, Lala A, Bagiella E, Moreno PR, Nadkarni GN, Ben-Yehuda O, Granada JF, Dressler O, Tinuoye EO, Granada C, Bustamante J, Peyra C, Godoy LC, Palacios IF, Fuster V. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol (2022) 79:917-928

Mensah GA, Fuster V. Sex and Gender Differences in Cardiovascular Health. J Am Coll Cardiol (2022) 79:1385-1387

Ibanez B, García-Lunar I, Fuster V. The Intima-Media Thickness Age Is Over: The Time of Multiterritorial Subclinical Plaque Quantification Has Come. J Am Coll Cardiol (2022) 79:1983-1985
Link to the full text in Repisalud

Kovacic JC, Fuster V. Exercise, Cardiovascular Disease, and the Athlete's Heart. J Am Coll Cardiol (2022) 80:1088-1090

Devesa A, Ibanez B, Fuster V Lp(a): Are Antithrombotic Therapies the Key to Event Reduction? J Am Coll Cardiol (2022) 80:1299-1301

Heymans S, Dawson D, Fuster V, Metra M, Tocchetti CG. Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions. J Am Coll Cardiol (2022) 80:1363-1365
Link to the full text in Repisalud

Cortes-Canteli M, Gispert JD, Salvadó G, Toribio-Fernandez R, Tristão-Pereira C, Falcon C, Oliva B, Mendiguren J, Fernandez-Friera L, Sanz J, Garcia-Ruiz JM, Fernandez-Ortiz A, Sanchez-Gonzalez J, Ibanez B, Molinuevo JL, Fuster V. Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study. J Am Coll Cardiol (2022) 42:4-5

Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators. Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial. Eur J Heart Fail (2022) 24:1816-1826

Hernandez-Vicente AA, Marti-Gomez C, Saura-Espin D, Oliva-Sandoval MJ, Pastor-Perez F, Riquelme-Perez A, Sanchez-Perez C, Asensio-Lopez MC, Espinosa MD, Gomez-Molina M, Caro C, Vivo-Molina JM, Franco-Nicolas M, Sanchez-Cabo F, Pascual-Figal DA. Longitudinal analysis of ejection fraction in heart failure with reduced ejection fraction patients: pharmacological treatment effects. Eur J Heart Fail (2022) 24:154-154

Crespo-Leiro M, Segovia-Cubero J, Almenar-Bonet L, Lara-Padron A, Garcia-Pinilla JM, Bonilla-Palomas JL, Lopez-Fernandez S, Mirabet-Perez S, Castro-Fernandez A, Diaz-Molina B, Goirigolzarri-Artaza J, Rincon LM, Pascual-Figal DA, Muniz J, Delgado-Jimenez JF. Spanish multicenter study on the monitoring and incidence of hyperkalaemia in patients with heart failure and reduced ejection fraction. SPANIK-HF Eur J Heart Fail (2022) 24:198-199